Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Nintedanib & Idiopathic Pulmonary Fibrosis, nintedanib is approved by both the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency) for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Nintedanib works in Idiopathic Pulmonary Fibrosis as phase III trials has shown: INPULSIS-1 (1), INPULSIS-2 (1), INBUILD (2). INBUILD was prospective, double-blind, randomized and placebo-controll…